United States · FDA National Drug Code directory
Diatrizoate Meglumine and Diatrizoate Sodium
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 53041-690_9cfdb214-1075-4449-9a01-f04cf5d0edfe
- Product NDC
- 53041-690
- Form
- SOLUTION
- Composition / generic term
- Diatrizoate Meglumine and Diatrizoate Sodium
- Labeler
- Guardian Drug Company
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20191218
- Source listing expiry
- 20261231
Source-listed ingredients
- DIATRIZOATE MEGLUMINE — 660 mg/mL
- DIATRIZOATE SODIUM — 100 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 120 mL in 1 BOTTLE, GLASS (53041-690-03) · 53041-690-03
- 30 mL in 1 BOTTLE, GLASS (53041-690-09) · 53041-690-09
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →